Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TKNO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
7 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 10
80 filers reported a long position in TKNO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ROYCE & ASSOCIATES LP | $9.4M | 1.7M | +55.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.2M | 1.6M | +265.3% |
| Roubaix Capital, LLC | $9M | 1.6M | -16.1% |
| BlackRock, Inc. | $5M | 879.8K | +22.7% |
| UBS Group AG | $3.6M | 632K | +94.4% |
| Conestoga Capital Advisors, LLC | $1.8M | 314.6K | -0.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $1.8M | 311.8K | +1.3% |
| BANK OF AMERICA CORP /DE/ | $1.5M | 255.8K | +12% |
| GOLDMAN SACHS GROUP INC | $977.1K | 172K | +45.2% |
| STATE STREET CORP | $936.5K | 164.9K | +6.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.